Charpentier, G <br/><br/>
Earlier triple therapy with pioglitazone in patients with type 2 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Sep 2009 
 - 844-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2009.01055.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--analysis<br/>C-Peptide--blood<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Homeostasis--drug effects<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--blood<br/>Insulin Resistance--physiology<br/>Lipids--blood<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Pioglitazone<br/>Proinsulin--blood<br/>Sulfonylurea Compounds--therapeutic use<br/>Thiazolidinediones--therapeutic use